Lai, S. (Contributor), Su, Y. (Contributor), Chi, C. (Contributor), Kuo, Y. (Contributor), Lee, K. (Contributor), Wu, Y. (Contributor), Lan, P. (Contributor), Yang, M. (Contributor), Chang, T. (Contributor), Huang, Y. (Contributor) (
1月 1 2019). MOESM1 of DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation. Unknown Publisher.
10.6084/m9.figshare.11273585.v1